Effect of potassium channel openers in acute and chronic models of glaucoma  by Panchal, Shital S. et al.
lable at ScienceDirect
Taiwan Journal of Ophthalmology 6 (2016) 131e135Contents lists avaiTaiwan Journal of Ophthalmology
journal homepage: www.e-t jo.comOriginal articleEffect of potassium channel openers in acute and chronic models
of glaucoma
Shital S. Panchal a, *, Anita A. Mehta b, Devdas D. Santani c
a Department of Pharmacology, Institute of Pharmacy, Nirma University, Ahmedabad 382481, Gujarat, India
b Department of Pharmacology, L.M. College of Pharmacy, Navarangpura, Ahmedabad 9, Gujarat, India
c Department of Pharmacy, NIMS University, Shobha Nagar, JaipureDelhi Highway (NH-11C), Jaipur 303121, Rajasthan, Indiaa r t i c l e i n f o
Article history:
Received 30 December 2015
Received in revised form
9 May 2016
Accepted 19 May 2016






potassium channelsConﬂicts of interest: No competing ﬁnancial interes
* Corresponding author. Department of Pharmaco
Nirma University, SG Highway, Ahmedabad 382481, G
E-mail address: panchalshital22@gmail.com (S.S. P
http://dx.doi.org/10.1016/j.tjo.2016.05.006
2211-5056/Copyright © 2016, The Ophthalmologic Soc
creativecommons.org/licenses/by-nc-nd/4.0/).a b s t r a c t
Purpose: Glaucoma is characterized by increased intraocular pressure (IOP). The effect of nicorandil and
pinacidil on IOP in experimentally induced acute and chronic models of glaucoma and the mechanism of
action involved were studied.
Methods: New Zealand white rabbits were used for the study. After the measurement of IOP, nicorandil
(1%), pinacidil (1%), and pilocarpine as standard (1%) were instilled topically into the left eye. The other
eye served as control. Dextrose (5%) was used to induce acute glaucoma. IOP changes were recorded
every 15 minutes until the pressure became normal. Freshly prepared a-chymotrypsin solution was
introduced in the posterior chamber to induce chronic glaucoma. Rabbits with ocular hypertension were
selected for the study. Similar drug solutions were used to study the effect on IOP. Glibenclamide,
pilocarpine, and indomethacin (1%) were used to study the mechanism of action of both drugs. The IOPs
were measured just prior to drug instillation and at suitable time intervals using a tonometer.
Results: Pretreatment with topical nicorandil and pinacidil signiﬁcantly lowered the rise in IOP in the
acute model. Nicorandil and pinacidil initially caused rise in IOP for 15e30 minutes in chronic glaucoma.
This was followed by reduction in IOP. Pretreatment with indomethacin and pilocarpine did not modify
the effect of nicorandil and pinacidil on IOP. Pretreatment with glibenclamide blocked IOP from the
lowering effect of nicorandil and pinacidil.
Conclusion: The oculohypotensive effect shown by these drugs appears to be attributable to enhance-
ment of the aqueous humor outﬂow. This effect is perhaps mediated through potassium channels.
Copyright © 2016, The Ophthalmologic Society of Taiwan. Published by Elsevier Taiwan LLC. This is an
open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Glaucoma is a multifactorial disease with a number of elements
contributing to its development. An elevation of intraocular pres-
sure (IOP) is a prominent component in optic nerve damage, which
is the hallmark of glaucoma. If the elevated IOP is inadequately
treated, progressive blindness may result.
Various drugs used in treatment of glaucoma are para-
sympathomimetics, b-adrenoceptor antagonists, carbonic anhy-
drase inhibitors, a2-adrenoceptor agonists, prostaglandin
analogues, and angiotensin-converting enzyme inhibitors.1,2
Timolol eye drops are the golden standard in the treatment oft exists.
logy, Institute of Pharmacy,
ujarat, India.
anchal).
iety of Taiwan. Published by Elseviglaucoma. However, timolol is also known to get into the systemic
circulation and causes various systemic effects.3 Although glau-
coma is known to be a serious chronic eye disease, an ideal agent to
be used in this disease is still not available, and there has been a
constant urge for the discovery of newer drugs.
The steady levels of IOP are the result of balanced aqueous hu-
mor formation and outﬂow. Calcium ﬂux could have several effects
on aqueous humor dynamics, including a hydrostatic component, a
result of arterial blood pressure and ciliary body perfusion, and an
osmotic component, which is a result of an effect on the active
secretion of sodium, calcium, and other ions by ciliary epithelium.4
It has been reported that functional Kþ-dependent ATP channels
are present in the trabecular meshwork, and their activation by
potassium channel openers can increase outﬂow facility through
the trabecular meshwork.5 Reports have indicated the beneﬁcial
effects of diazoxide and nicorandil on Kþ-dependent ATP channel-
mediated IOP regulation.6 Cromakalim and nicorandil wereer Taiwan LLC. This is an open access article under the CC BY-NC-ND license (http://
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hypertensive rabbits.7 According to Food and Drug Administration
reports, 0.0353% patients suffer from glaucoma after treatment
with nicorandil in various disease conditions.8 In the present study,
we investigated the effect of potassium channel openers, pinacidil
and nicorandil, and their interaction with a potassium channel
blocker, glibenclamide, for their effect on IOP. Furthermore, the
possible mechanisms of action of these agents were also studied.
2. Materials and methods
2.1. Experimental animals
New Zealand white rabbits of either sex weighing 1.5e2.5 kg
(Zydus Research Center, Ahmedabad, India) were housed under
well-controlled conditions: temperature, 22 ± 2C; humidity,
55 ± 5%; and 12/12-hour light/dark cycle. They were given access to
food and water ad libitum. The protocol of the experiment was
approved by the Institutional Animal Ethical Committee as per the
guidance of the Committee for the Purpose of Control and Super-
vision of Experiments on Animals, Ministry of Social Justice and
Empowerment, Government of India.
2.2. Acute glaucoma model
The basal IOP was measured using a Schiotz-type indentation
tonometer. The drug solutions were prepared in suitable solvents
and were instilled topically into the left eye. The drug solutions
used in the study were nicorandil (1% in phosphate buffer, pH 7.4),
pinacidil (1% in PEG 400), glibenclamide (1% in PEG 400), and
pilocarpine (1%; FDC Ltd., Maharastra, India). The right eye, which
served as control, received the vehicle. After 15 minutes of drug
administration, 5% dextrose solution (15 mL/kg) was intravenously
(i.v.) infused through the marginal ear vein up to 15 minutes. Six
rabbits (of either sex) were taken to study the effect of each drug. A
5% dextrose infusion induced an acute increase in IOP in both eyes
of all rabbits under study. IOP was recorded every 15 minutes until
the pressure became normal.9
2.3. Chronic glaucoma model
Albino rabbits were sedated with diazepam (1 mg/kg, i.v.) and
anesthetized with ketamine (25 mg/kg, i.v.). Fresh a-chymotrypsin
(50 units; Sigma Life Sciences, Missouri, USA) solution prepared in
0.1 mL of sterile saline was irrigated through the cannula into the
posterior chamber.9 The debris of tissue blocked the pathway of the
aqueous humor outﬂow in the trabecular meshwork to induce
ocular hypertension.10 a-Chymotrypsin was administered in 36
rabbit eyes. From this, we have successfully increased IOP in 27
eyes. Rabbit with increased IOP above 30 mmHg were selected and
used to determine the effect of drugs on IOP. After a steady elevated
IOP was achieved, similar drug solutions as in acute glaucoma
model were administered topically into the left eye, whereas the
right eye served as control. The IOPs were measured at time 0 (just
before eye drop instillation), 15, 30, 45, 60, 75, 90, 120, 180, 240,
300, and 360 minutes using a tonometer.
2.4. Studies on interaction of glibenclamide with nicorandil and
pinacidil in acute glaucoma model in rabbits
The basal IOP was measured in both eyes. After 15 minutes of
glibenclamide instillation in the left eye, nicorandil or pinacidil
were instilled topically. The right eye served as control. The acute
glaucoma model was produced using the procedure describedabove.9 IOP was recorded with a tonometer every 15 minutes until
the pressure became normal.
2.5. Studies on interaction of glibenclamide with nicorandil and
pinacidil in chronic glaucoma model in rabbits
Rabbits with a-chymotrypsin-induced glaucoma were selected
for the study. The IOP was initially recorded with the help of a
tonometer. The interaction study was carried out similarly as in the
acute model.
2.6. Studies on interaction of indomethacin and pilocarpine with
nicorandil and pinacidil in chronic glaucoma model in rabbits
Rabbits with a-chymotrypsin-induced glaucoma were selected
for the study. The IOP was initially recorded with the help of a
tonometer. Indomethacin (1%; Sterﬁl Laboratories Pvt. Ltd.,
Maharastra, India) prostaglandin inhibitor was topically adminis-
tered to the left eye. The right eye served as control. After 45 mi-
nutes of administration of indomethacin, nicorandil or pinacidil
was instilled topically. The changes in IOPs were recorded at suit-
able time intervals using a tonometer. Indomethacin was replaced
with pilocarpine to study the interaction of pilocarpine with nic-
orandil and pinacidil.
These formulations were ﬁrst tested in rabbit’s eyes for ocular
safety. No ill effects were observed.
2.7. Statistical analysis
Paired Student t test was used for determining the statistical
signiﬁcance of most of the data at the probability level of 95%. A
split-plot analysis of variancewas carried out for studying the time-
dependent interaction between the drugs under study and other
drugs.
3. Results
An acute elevation in IOP of up to 30e35 mmHg was observed
when 5% dextrose (15 mL/kg) was administered intravenously.
Potassium channel blocker, glibenclamide (1%) partially reversed
IOP lowering effect of nicorandil (1%) and pinacidil (1%) in acute
glaucoma in rabbits (Figures 1 and 2, respectively).
The topical administration of nicorandil in animals with a-
chymotrypsin-induced ocular hypertension produced a signiﬁcant
drop in IOP (from 33.67 ± 0.31 mmHg to 20.10 ± 0.01mmHg) after
an initial rise (from 33.67 ± 0.31mmHg to 42.17 ± 0.07mmHg), and
the topical administration of pinacidil in rabbits with a-chymo-
trypsin-induced occular hypertension produced a signiﬁcant drop
in IOP (from 33.93 ± 0.43 mmHg to 21.30 ± 0.30 mmHg) after an
initial rise (from 33.93 ± 0.43 mmHg to 38.77 ± 0.84 mmHg) in IOP
(Figures 3 and 4, respectively).
Glibenclamide reversed the OP-lowering effect of nicorandil and
pinacidil in rabbits with a-chymotrypsin-induced chronic glau-
coma (Figures 3 and 4, respectively). Interactionwith indomethacin
(1%) or pilocarpine (1%) did not produce a signiﬁcant change in the
IOP-lowering effect of nicorandil and pinacidil (Figures 3 and 4,
respectively).
4. Discussion
Glaucoma is an eye disease with elevated IOP as a prominent
and hallmark component. It has been reported that glaucoma has
vascular roots, as it is more prevalent in cardiovascular and cere-
brovascular diseases,11,12 and in Raynaud-like peripheral circulation
disease.13
Figure 1. Effect of nicorandil (1%), [nicorandil (1%) þ glibenclamide (1%)], and pilo-
carpine (1%) on IOP in acute glaucoma model in rabbits. Each point and bar represents
mean ± SEM of six observations. * Signiﬁcantly different from control (p < 0.05). **
Signiﬁcantly different from nicorandil (p < 0.05). IOP ¼ intraocular pressure;
SEM ¼ standard error of the mean.
Figure 2. Effect of pinacidil (1%), [pinacidil (1%) þ glibenclamide (1%)], and pilo-
carpine (1%) on IOP in acute glaucoma model in rabbits. Each point and bar repre-
sents mean ± SEM of six observations. * Signiﬁcantly different from control
(p < 0.05). ** Signiﬁcantly different from pinacidil (p < 0.05). IOP ¼ intraocular
pressure; SEM ¼ standard error of the mean.
Figure 3. Effect of nicorandil (1%), [glibenclamide (1%) þ nicorandil (1%)], [pilocarine
(1%) þ nicorandil (1%)], [indomethacine (1%) þ nicorandil (1%)], and pilocarpine (1%)
on IOP in rabbits with a-chymotrypsin-induced ocular hypertension. Each point and
bar represents mean ± SEM of six observations. * Signiﬁcantly different from control
(p < 0.05). ** Signiﬁcantly different from nicorandil (p < 0.05). IOP ¼ intraocular pres-
sure; SEM ¼ standard error of the mean.
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channel openers, nicorandil and pinacidil, in experimentally
induced acute and chronic glaucomatic rabbit models. Oral water
loading and the more advantageous alternative, 5% dextroseinfusion through themarginal ear vein, comprise one of the easiest,
fastest, and reliable techniques to screen antiglaucoma agents. Oral
water loading or 5% dextrose infusion leads to reduction in blood
osmolality, which leads to transfer of water into the eye, causing
elevation of IOP.14 We have studied the oculohypotensive effect of
potassium channel openers, nicorandil and pinacidil. In the acute
model of glaucoma, nicorandil and pinacidil induced a signiﬁcant
drop in IOP. Chronic and stable elevation of IOP was achieved by
introducing a-chymotrypsin into the posterior chamber of the
rabbit eye. The sustained elevation in IOP was triggered by an in-
ﬂammatory reaction in the trabecular meshwork.15 In rabbits with
a-chymotrypsin-induced glaucoma tic, nicorandil and pinacidil
initially caused IOP to increase for 15e30 minutes, which was later
followed by a reduction in IOP.
We studied the interaction of glibenclamide with nicorandil and
pinacidil. The topical administration of glibenclamide had signiﬁ-
cantly reversed the fall in IOP induced by nicorandil or pinacidil in
acute as well as chronic models of glaucoma. This indicates that
nicorandil and pinacidil may exert their oculohypotensive effect by
affecting the potassium channels, which is in accordance with the
reports of Kelly and Walley16 and Santafe et al.17
Prostaglandin analogs are known to reduce IOP by increasing
the uveoscleral outﬂow.18 Pilocarpine reduces the uveoscleral
outﬂow by providing a stretching of the scleral spur through which
PGF2a reduces IOP.19 Pilocarpine is reported to decrease the
uveoscleral outﬂow by an opposite mechanism of action to pros-
taglandin analogues, and it may cause a paradoxical rise in IOP in
Figure 4. Effect of pinacidil (1%), [glibenclamide (1%) þ pinacidil (1%)], [pilocarine
(1%) þ pinacidil (1%)], [indomethacine (1%) þ pinacidil (1%)], and pilocarpine (1%) on
IOP in rabbits with a-chymotrypsin-induced ocular hypertension. Each point and bar
represents mean ± standard error of the mean of six observations. * Signiﬁcantly
different from control (p < 0.05). ** Signiﬁcantly different from pinacidil (p < 0.05).
IOP ¼ intraocular pressure; SEM ¼ standard error of the mean.
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explore the IOP-lowering mechanism of nicorandil and pinacidil,
we have studied the interaction of indomethacin and pilocarpine
with these drugs. In the interaction of indomethacin and pilocar-
pine with nicorandil and pinacidil, a topical administration of
indomethacin was unable to alter the fall in IOP induced by nicor-
andil or pinacidil. Pilocarpine failed tomodify the oculohypotensive
effects produced by nicorandil or pinacidil. This suggests the
noninvolvement of the uveoscleral pathway in lowering the IOP by
nicorandil and pinacidil.
Potassium channel openersmay inhibit the ability of intracellular
Ca2þ stores to reﬁll after Ca2þ release has occurred.21 Opening of Kþ
channels by potassium channel openers hyperpolarizes the mem-
brane and thus decreases the Ca2þ concentration and tendency for
the membrane to become depolarized by excitatory transmitters.
Calcium channel blockers cause vasodilation and thus reduce
vascular resistance. They increase the capillary blood in the optic
nerve head.22e24 This may make them suitable for trial in the
treatment of low-tension glaucoma. L-type and T-type calcium
channels seem to play a role in cellular growth, and thus calcium
antagonists can inhibit the growth and proliferation of vascular
smooth muscle and ﬁbroblasts. Calcium antagonists may also
inhibit the synthesis of extracellular-matrix collagen proteins,
suggesting a beneﬁcial effect in glaucoma.25
Santafe et al17 reported that calcium channel blockers (CCBs)
decrease aqueous humor secretion, although they also cause aslight but signiﬁcant reduction of tonographic outﬂow facility.
Moreover, the reduced outﬂow of aqueous humor caused by raised
episcleral venous pressure may be directly increased by calcium
inhibition.4 Furthermore, Gap junctions, possibly regulated by cal-
cium, exist between nonpigmented and pigmented ciliary epithe-
lial cells. Verapamil may interferewith these gap junctions, altering
the cellular permeability of the ciliary epithelium and thus inhib-
iting normal aqueous humor formation.26
The synthesis of aqueous humor is dependent on the catalytic
formation of HCO3e from CO2 in ciliary processes, in which Naþ is
possibly linked to HCO3emovement.27 Wolosin et al28 reported that
the transport of HCO3e is related to the concentration of potassium
ionwhen the extracellular potassium is increased. The intracellular
pH is also increased, which causes cell depolarization and elicited a
Naþ-HCO3e inﬂux to decrease the formation of aqueous humor.28
Nicorandil and pinacidil are potassium channel activators, which
increase the cell membrane permeability to potassium and produce
membrane hyperpolarization. As the effect is opposite to cell de-
polarization, the formation of aqueous humor is increased. Another
possible mechanism is that the aqueous humor formation is related
to Naþ/Kþ-ATPase, the enzyme distributed in the epithelium layer
of ciliary body. Hþ is formed by the catalysis of carbonic anhydrase
and exchanged with Naþ of the extracellular ﬂuid. Then, intracel-
lular sodium is exchanged with Kþ in the posterior chamber to
produce an osmotic pressure. Consequently, water enters the pos-
terior chamber of the eye to form aqueous humor.29,30 Hong et al31
reported that cromakalim indirectly activates the Naþ/Kþ-ATPase,
which is inhibited by ouabain. Thus, the mechanism of potassium
channel openers under studydi.e., nicorandil and pinacidildwas
found to be similar to that of cromakalim. This might explain the
increase in IOP during the initial period in chronic models of
glaucoma after the topical administration of nicorandil and pina-
cidil. The possible mechanism for the lowering of IOP may be same
as that of CCBs. However CCBs are also reported for elevation of
IOP.32
Because of the initial rise in IOP even in ocular hypertensive
rabbits, it may not be possible to infer whether or not potassium
channel openers are the right candidates for trial in glaucoma.
In conclusion, our data suggest that nicorandil and pinacidil
produced an initial rise in IOP. This may be attributable to the in-
crease in aqueous humor formation. The oculohypotensive effect
shown by these drugs appears to be due to enhancement of
aqueous humor outﬂow. This effect is perhaps mediated through
potassium channels.Acknowledgments
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